Lucigen Corp., a Middleton biotech firm, said Monday it has been awarded $350,000 in grants from the National Institutes of Health to fund additional research and development. The two grants will be used to develop genetic sequencing tools, and to create an affordable tool to help researchers study data from genes and proteins within individual cells. Read full Journal Sentinel story here.